TrialArthritis research & therapy2013

A phase Ib multiple ascending dose study evaluating safety, pharmacokinetics, and early clinical response of brodalumab, a human anti-IL-17R antibody, in methotrexate-resistant rheumatoid arthritis.

David A Martin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.